Maze Therapeutics, Inc. · NASDAQ:MAZE
Bachrodt Amy sold 2,500 Maze Therapeutics, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 2, 2026
On Apr 1, 2026, Bachrodt Amy (SVP, Finance) sold 2,500 Maze Therapeutics, Inc. shares at an average US$29.44 for US$73,606 under a trading plan, leaving 12,965 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 2,500 shares
- Price
- US$29.44 average (US$29.32 to US$30.34)
- Value
- US$73,606
- Holding after
- 12,965 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, Finance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Option exercise | 2,500 | US$10.42 | 15,465 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 2,200 | US$29.32 | 13,265 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 300 | US$30.34 | 12,965 | Direct |